The dexamethasone suppression test in schizophrenia

Psychological Medicine

Volumn 28, Issue 2, 1998, Pages 311-317

  Ismail, K ^a   Murray, R M ^b   Wheeler, M J ^b   O'Keane, V ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CORRELATION FUNCTION; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; ORAL DRUG ADMINISTRATION; RATING SCALE; SCHIZOPHRENIA; SUICIDE ATTEMPT;

ADULT; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DEPRESSION; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; SCHIZOPHRENIA, PARANOID; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED;

EID: 0031978298     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291797006521     Document Type: Article

References (39)

1. Abel, K. M., O'Keane, V. & Murray, R. M. (1996). Enhancement of the prolactin response to D-fenfluramine in drug-naive schizophrenic patients. British Journal of Psychiatry 168, 57-60.
2. Addington, D. & Addington, J. (1990). Depression, dexamethasone non-suppression and negative symptoms in schizophrenia. Canadian Journal of Psychiatry 35, 430-433.
3. Altamura. C., Guercetti, G. & Percudani, M. (1989). Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Research 30, 69-75.
4. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
5. American Psychiatric Association Task Force on Laboratory Tests in Psychiatry (1987). The dexamethasone suppression test: an overview of its current status in psychiatry. American Journal of Psychiatry 144, 1253-1262.
6. Andreasen, N. C. (1982). Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry 39, 784-788.
7. Arana, G. W., Workman, R. J. & Baldessarini, R. J. (1984). Association between low plasma levels of dexamethasone and elevated levels of Cortisol in psychiatric patients given dexamethasone. American Journal of Psychiatry 141, 1619-1620.
8. Barnes, T. R., Curson, D. A., Liddle, P. F. & Patel, M. (1989). The nature and prevalence of depression in chronic schizophrenic inpatients. British Journal of Psychiatry 154, 486-491.
9. Baumgartner, A., Graf, K. J. & Kurten, I. (1985). The dexamethasone suppression test in depression, in schizophrenia and during experimental stress. Biological Psychiatry 20, 675-679.
10. Carroll, B. J., Feinberg, M., Greden, J., Tarika, J., Albala, A. A., Haskett, R. R., James, N. McI., Kronfol, Z., Lohr, N., Steiner, M., DeVigne, J. P. & Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry 38, 15-22.
11. Ceulemans, D. L. S., Westenberg, H. G. M. & van Praag, H. M. (1985). The effect of stress on the dexamethasone suppression test. Psychiatry Research 14, 189-195.
12. Coppen, A., Abou-Saleh, M., Milln, P., Metcalfe, M., Harwood, J. & Bailey, J. (1983). Dexamethasone suppression test in depression and other psychiatric disorders. British Journal of Psychiatry 142, 498-504.
13. Coryell, W. & Tsuang, D. (1992). Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8 year followup. American Journal of Psychiatry 149, 1033-1039.
14. Davis, K. L., Davis, B. M., Mathe, A. A., Mohs, R. C., Rothpearl, A. B., Levy, M. I., Gorman, L. K. & Berger, P. (1984). Age and dexamethasone suppression test in depression. American Journal of Psychiatry 141, 872-874.
15. Dewan, M., Pandurangi, A., Lewy, B., Boucher, M. & Major, L. (1985). Are schizophrenics with abnormal dexamethasone suppression test results a distinct subgroup? Acta Psychiatrica Scandinavica 72, 274-277.
16. Garyfollos, G., Lavrentiadis, G., Amoutzias, D., Monas, K. & Manos, N. (1993). Negative symptoms of schizophrenia and the dexamethasone suppression test. Acta Psychiatrica Scandinavica 88, 425-428.
17. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
18. Herz, M. I., Fava, G. A., Molnar, G. & Edwards, L. (1985). The dexamethasone suppression test in newly hospitalised schizophrenic patients. American Journal of Psychiatry 142, 127-129.
19. Holsboer, F., Wiedemann, K. & Boll, E. (1986). Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors. Archives of General Psychiatry 43, 813-815.
20. Holsboer-Trachsler, E., Buol, C., Wiedemann, K. & Holsboer, F. (1987). Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels. Acta Psychiatrica Scandinavica 75, 608-613.
21. Jones, J. S., Stein, D. J., Stanley, B., Guido, J. R., Winchel, R. & Stanley, M. (1994). Negative and depressive symptoms in suicidal schizophrenics. Acta Psychiatrica Scandinavica 89, 81-87.
22. Kulhara, P., Avasthia, A., Chadda, R., Chandiramani, K., Mattoo, S, K., Kota, S. K. & Joseph, S. (1989). Negative and depressive symptoms in schizophrenia. British Journal of Psychiatry 154, 207-211.
23. McGauley, G. A., Aldridge, C. R., Fahy, T. A. & Eastment, C. (1989). The dexamethasone suppression test and negative symptoms of schizophrenia. Acta Psychiatrica Scandinavica 80, 548-553.
24. Meilke, W. A. (1982). Dexamethasone suppression test: usefulness of simultaneous measurement of plasma Cortisol and dexamethasone. Clinical Endocrinology 16, 401-408.
25. Miles, P. (1977). Conditions predisposing to suicide: a review. Journal of Nervous and Mental Disease 164, 231-246.
26. Mina, I., Jackson, H., Joshua, S. & Burgess, P. (1990). Depression, negative and positive symptoms, and the DST in schizophrenia. Schizophrenia Research 5-6, 321-327.
27. Munro, J., Hardiker, T. & Leonard, D. (1984). The dexamethasone suppression test in residual schizophrenia with depression. American Journal of Psychiatry 141, 250-252.
28. Newcomer, J. W., Faustman, W. O., Yeh, W. & Csernansky, J. G. (1990). Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia. Psychiatry Research 31, 243-250.
29. O'Sullivan, B. T., Cutler, D. J., Hunt, D. J., Hunt, G. E., Walters, C., Johnson, G. F. & Caterson, I. D. (1997). Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy controls subjects. Biological Psychiatry 41, 574-584.
30. Overall, J. E. & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports 10, 799-812.
31. Roy, A. (1981). Depression in the course of chronic undifferentiated schizophrenia. Archives of General Psychiatry 38, 296-297.
32. Saffer, D., Metcalfe, M. & Coppen, A. (1985). Abnormal dexamethasone suppression test in Type II schizophrenia. British Journal of Psychiatry 147, 721-723.
33. Sawyer, J. & Jeffries, J. J. (1984). The dexamethasone suppression test in schizophrenia. Journal of Clinical Psychiatry 45, 399-402.
34. Sharma, R., Pandey, G., Janicak. P., Peterson, J., Comaty, J. E. & Davis, J. M. (1988). The effect of diagnosis and age on the DST: a meta-analytic approach. Biological Psychiatry 24, 555-568.
35. Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A. Meador-Woodruff, J. H., Goldman, R. & Greden, J. F. (1991). Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement and outcome. Biological Psychiatry 29, 953-964.
36. Whiteford, H., Riney, S., Savala, R. & Csernansky, J. (1988). Dexamethasone non-suppression in chronic schizophrenia. Acta Psychiatrica Scandinavica 77, 58-62.
37. Wik, G., Wiesel, F. A., Eneroth, P., Sevall, G. & Astrom, G. (1986). Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiatrica Scandinavica 74, 161-167.
38. Udhe, T. W., Bierer, L. M. & Post, R. M. (1985). Caffeine-induced escape from dexamethasone suppression. Archives of General Psychiatry 42, 737-738.
39. Yeragani, V. K. (1990). The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls. Canadian Journal of Psychiatry 35, 128-132.